Back

Abnormal Lipid Metabolism and Altered Neuronal Support by Astrocytes Lacking Akap11, a Risk Gene for Schizophrenia and Bipolar Disorder

Liu, X.-M.; Pribiag, H.; Misri, D.; Kim, K.; Mandell, K. P.; Song, B. J.; Graykowski, D.; Seidel, O.; Hartley, N. D.; Herrera, M.; Xu, H. J.; Tegtmeyer, M.; Zhang, Y.-L.; Cui, L.; Clark, N.; Huang, W.-C.; Adeleye, J.; Dennis, C.; Dailey, L.; Deik, A.; Inunciaga, L.; Mashin, E.; Simmons, S. K.; Pan, J. Q.; Nehme, R.; Keshishian, H.; Carr, S. A.; Fu, Z.; Levin, J. Z.; Clish, C. B.; Sheng, M.

2025-04-25 cell biology
10.1101/2025.04.25.650548 bioRxiv
Show abstract

A-Kinase Anchoring Protein 11 (AKAP11) is a shared genetic risk factor for schizophrenia and bipolar disorder, yet its role in the brain remains poorly understood. Through multi-omic analysis of Akap11 mutant mouse brains and cultured astrocytes, we identified significant transcriptomic, proteomic, and metabolomic alterations. Key findings include the upregulation of cholesterol and fatty acid metabolic pathways, accumulation of lipid species such as cholesteryl esters, triacylglycerols, ceramides, and glycerophospholipids, and elevated levels of 3,5-cyclic AMP and protein kinase A (PKA) signaling. These metabolic perturbations manifested as increased lipid droplet accumulation in Akap11 mutant astrocytes, highlighting AKAP11s critical role in regulating intracellular lipid homeostasis. Mechanistically, AKAP11 functions as an autophagy receptor mediating PKA degradation and interacts with endoplasmic reticulum-resident proteins VAP-A and VAP-B through its FFAT motif, providing possible molecular insight into AKAP11s regulation of lipid metabolism. Co-culture experiments with mouse astrocytes and human induced pluripotent stem cell-derived neurons demonstrated that loss of Akap11 in astrocytes, relative to wild-type, increases excitatory neurotransmission and neuronal activity. Collectively, these findings link AKAP11-mediated lipid and synaptic dysregulation to psychiatric disease risk and highlight the potential role of astrocytes in these disorders.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Molecular Psychiatry
242 papers in training set
Top 0.1%
23.7%
2
Neurobiology of Disease
134 papers in training set
Top 0.9%
5.1%
3
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 0.8%
5.1%
4
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.1%
4.5%
5
Nature Communications
4913 papers in training set
Top 34%
4.5%
6
Cell Reports
1338 papers in training set
Top 14%
3.8%
7
Biological Psychiatry
119 papers in training set
Top 1%
2.2%
8
PLOS ONE
4510 papers in training set
Top 47%
2.2%
50% of probability mass above
9
Scientific Reports
3102 papers in training set
Top 48%
2.2%
10
Schizophrenia Bulletin
29 papers in training set
Top 0.4%
2.0%
11
Cell Reports Medicine
140 papers in training set
Top 3%
1.8%
12
Journal of Clinical Investigation
164 papers in training set
Top 3%
1.6%
13
PLOS Biology
408 papers in training set
Top 11%
1.6%
14
eLife
5422 papers in training set
Top 44%
1.6%
15
JCI Insight
241 papers in training set
Top 4%
1.6%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 34%
1.6%
17
PLOS Genetics
756 papers in training set
Top 10%
1.4%
18
Translational Psychiatry
219 papers in training set
Top 3%
1.4%
19
Biology of Sex Differences
29 papers in training set
Top 0.4%
1.3%
20
iScience
1063 papers in training set
Top 20%
1.3%
21
Communications Biology
886 papers in training set
Top 15%
1.2%
22
Science Advances
1098 papers in training set
Top 25%
1.0%
23
Molecular Cell
308 papers in training set
Top 9%
1.0%
24
Journal of Biological Chemistry
641 papers in training set
Top 3%
0.9%
25
Frontiers in Molecular Biosciences
100 papers in training set
Top 3%
0.9%
26
Gastroenterology
40 papers in training set
Top 1%
0.9%
27
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
28
Cell Death & Disease
126 papers in training set
Top 2%
0.8%
29
Human Molecular Genetics
130 papers in training set
Top 3%
0.8%
30
Neuropsychopharmacology
134 papers in training set
Top 3%
0.7%